Lorenzo Dutto

Lorenzo Dutto

Auto-generated profile, based on publicly available information

Lorenzo Dutto

Prostatazentrum Nordwest, St. Antonius-Hospital, Klinik für Urologie, Kinderurologie und Urologische Onkologie, Gronau, Germany.

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
EDEoin Dinneen
Eoin Dinneen
CAClare Allen
Clare Allen
TSTom Strange
Tom Strange
DHDaniel Heffernan Ho
Daniel Heffernan Ho
JBJelena Banjeglav
Jelena Banjeglav
SPShonit Punwani
Shonit Punwani
Background: The accuracy of multi-parametric MRI (mpMRI) in the pre-operative staging of prostate cancer (PCa) remains controversial. Objective: The purpose of this study was to evaluate the ability of mpMRI to accurately predict PCa extra-prostatic extension (EPE) on a side-specific basis using a risk-stratified 5-point Likert scale. This study also aimed to assess the influence of mpMRI scan quality on diagnostic accuracy. Patients and Methods: We included 124 men who underwent robot-assisted RP (RARP) as part of the NeuroSAFE PROOF study at our centre. Three radiologists retrospectively reviewed mpMRI blinded to RP pathology and assigned a Likert score (1–5) for EPE on each side of the prostate. Each scan was also ascribed a Prostate Imaging Quality (PI-QUAL) score for assessing the quality of the mpMRI scan, where 1 represents the poorest and 5 represents the best diagnostic quality. Outcome measurements and statistical analyses: Diagnostic performance is presented for the binary classification of EPE, including 95% confidence intervals and the area under the receiver operating characteristic curve (AUC). Results: A total of 231 lobes from 121 men (mean age 56.9 years) were evaluated. Of these, 39 men (32.2%), or 43 lobes (18.6%), had EPE. A Likert score ≥3 had a sensitivity (SE), specificity (SP), NPV, and PPV of 90.4%, 52.3%, 96%, and 29.9%, respectively, and the AUC was 0.82 (95% CI: 0.77–0.86). The AUC was 0.76 (95% CI: 0.64–0.88), 0.78 (0.72–0.84), and 0.92 (0.88–0.96) for biparametric scans, PI-QUAL 1–3, and PI-QUAL 4–5 scans, respectively. Conclusions: MRI can be used effectively by genitourinary radiologists to rule out EPE and help inform surgical planning for men undergoing RARP. EPE prediction was more reliable when the MRI scan was (a) multi-parametric and (b) of a higher image quality according to the PI-QUAL scoring system.

19 July 2013 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
LDL. Dutto
L. Dutto
BOB. O’rEilly
B. O’rEilly

27 November 2018 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
LDLorenzo Dutto
Lorenzo Dutto
AAAmar Ahmad
Amar Ahmad
KUKaterina Urbanova
Katerina Urbanova
CWChristian Wagner
Christian Wagner
ASAndreas Schuette
Andreas Schuette
GSGregory L. Shaw
Gregory L. Shaw
Background Active surveillance is recommended for insignificant prostate cancer (PCa). Tools exist to identify suitable candidates using clinical variables. We aimed to develop and validate a novel risk score (NRS) predicting which patients are harbouring insignificant PCa. Methods We used prospectively collected data from 8040 consecutive unscreened patients who underwent radical prostatectomy between 2006 and 2016. Of these, data from 2799 patients with Gleason 3 + 3 on biopsy were used to develop a multivariate model predicting the presence of insignificant PC at radical prostatectomy (ERSPC updated definition3: Gleason 3 + 3 only, index tumour volume < 1.3 cm3 and total tumour volume < 2.5 cm3). This was used to develop a novel risk score (NRS) which was validated in an equivalent independent cohort (n = 441). We compared the accuracy of existing predictive tools and the NRS in these cohorts. Results The NRS (incorporating PSA, prostate volume, age, clinical T Stage, percent and number of positive biopsy cores) outperformed pre-existing predictive tools in derivation and validation cohorts (AUC 0.755 and 0.76, respectively). Selection bias due to analysis of a surgical cohort is acknowledged. Conclusions The advantage of the NRS is that it can be tailored to patient characteristics and may prove to be valuable tool in clinical decision-making.

15 March 2019 in European Urology Supplements
Verified
Journal Article
Closed access
PDF file
CNCosimo De Nunzio
Cosimo De Nunzio
Antonio Luigi PastoreAntonio Luigi Pastore
Antonio Luigi Pastore
RLR. Lombardo
R. Lombardo
ANAntonio Nacchia
Antonio Nacchia
ACA. Carbone
A. Carbone
JWJ.H. Witt
J.H. Witt

20 May 2017 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
LDLorenzo Dutto
Lorenzo Dutto
JWJorn H. Witt
Jorn H. Witt
KUKatarina Urbanova
Katarina Urbanova
CWChristian Wagner
Christian Wagner
ASAndreas Schuette
Andreas Schuette
GSGregory Shaw
Gregory Shaw
5073 Background: Active surveillance is increasingly used for insignificant prostate cancer (PCa). In order to identify suitable patients, risk scores have been developed which use pre-operative factors. We evaluated the accuracy of 9 separate tools developed to identify patients harbouring insignificant PCa in 2613 patients who underwent radical prostatectomy for Gleason 3+3 PCa. We have developed and validated a novel risk score to correctly identify insignificant PCa for use in unscreened patient cohorts using non-dichotomised clinical predictors. Methods: 2799 patients who would have been candidates for AS (Gleason score 6 only) patients underwent robotic radical prostatectomy between 2006 and 2016 at a tertiary referral center. The volume and grade of tumour in the resected prostate was analysed. Inignificant PCa was defined as Gleason 3+3 only, index tumour volume

1 September 2017 in European Urology Supplements
Verified
Journal Article
Closed access
MAM. Addali
M. Addali
LDL. Dutto
L. Dutto
JMJ. Moellers
J. Moellers
LEL. Esch
L. Esch
JWJ.H. Witt
J.H. Witt